CORC

在结果中检索

CORC

浏览/检索结果: 共175条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
Safety, Clinical Activity, and Pharmacokinetics of Al flutinib (AST2818) in Patients With Advanced NSCLC With EGFR T790M Mutation 期刊论文
JOURNAL OF THORACIC ONCOLOGY, 2020, 卷号: 15, 期号: 6, 页码: 1015-1026
作者:  Shi, Yuankai;  Zhang, Shucai;  Hu, Xingsheng;  Feng, Jifeng;  Ma, Zhiyong
收藏  |  浏览/下载：43/0  |  提交时间：2020/12/24
Management of anlotinib-related adverse events in patients with advanced non-small cell lung cancer: Experiences in ALTER-0303. 期刊论文
Thoracic cancer, 2019, 卷号: 10, 页码: 551-556
作者:  Si Xiaoyan;  Zhang Li;  Wang Hanping;  Zhang Xiaotong;  Wang Mengzhao
收藏  |  浏览/下载：35/0  |  提交时间：2019/11/19
Tracking longitudinal genetic changes of circulating tumor DNA (ctDNA) in advanced Lung adenocarcinoma treated with chemotherapy 期刊论文
2019, 卷号: 17, 期号: 1, 页码: 339
作者:  Han Xiaohong;  Han Ying;  Tan Qiaoyun;  Huang Yu;  Yang Jianliang
收藏  |  浏览/下载：19/0  |  提交时间：2020/01/03
Anti-p53 autoantibody in blood as a diagnostic biomarker for colorectal cancer: a meta-analysis 期刊论文
2019, 页码: e12829
作者:  Liu Shuxia;  Tan Qiaoyun;  Song Yuanyuan;  Shi Yuankai;  Han Xiaohong
收藏  |  浏览/下载：4/0  |  提交时间：2020/01/03
Co-mutational assessment of circulating tumour DNA (ctDNA) during osimertinib treatment for T790M mutant lung cancer 期刊论文
2019
作者:  Xing Puyuan;  Han Xiaohong;  Wang Sha;  Liu Yutao;  Yang Sheng
收藏  |  浏览/下载：22/0  |  提交时间：2020/01/03
Comprehensive Profiling of Gene Copy Number Alterations Predicts Patient Prognosis in Resected Stages I-III Lung Adenocarcinoma 期刊论文
2019, 卷号: 9, 页码: 556
作者:  Han, Xiaohong;  Tan, Qiaoyun;  Yang, Sheng;  Li, Junling;  Xu, Jianping
收藏  |  浏览/下载：20/0  |  提交时间：2020/01/03
Clinical features and outcomes of diffuse large B-cell lymphoma based on nodal or extranodal primary sites of origin: Analysis of 1,085 WHO classified cases in a single institution in China 期刊论文
2019, 卷号: 31, 期号: 1, 页码: 152-161
作者:  Shi, Yuankai;  Han, Ying;  Yang, Jianliang;  Liu, Peng;  He, Xiaohui
收藏  |  浏览/下载：6/0  |  提交时间：2020/01/03
Antitumor activity of histone deacetylase inhibitor chidamide alone or in combination with epidermal growth factor receptor tyrosine kinase inhibitor icotinib in NSCLC 期刊论文
2019, 卷号: 10, 期号: 5, 页码: 1275-1287
作者:  Zhang, Ningning;  Liang, Caixia;  Song, Wenya;  Tao, Dan;  Yao, Jiarui
收藏  |  浏览/下载：8/0  |  提交时间：2020/01/03
Management of anlotinib-related adverse events in patients with advanced non-small cell lung cancer: Experiences in ALTER-0303 期刊论文
2019, 卷号: 10, 期号: 3, 页码: 551-556
作者:  Si, Xiaoyan;  Zhang, Li;  Wang, Hanping;  Zhang, Xiaotong;  Wang, Mengzhao
收藏  |  浏览/下载：13/0  |  提交时间：2020/01/03
Prognostic Nomogram for Overall Survival in Patients with Diffuse Large B-Cell Lymphoma 期刊论文
2019
作者:  Han Ying;  Yang Jianliang;  Liu Peng;  He Xiaohui;  Zhang Changgong
收藏  |  浏览/下载：5/0  |  提交时间：2020/01/03

©版权所有 ©2017 CSpace - Powered by CSpace